Type 2 Diabetes with Celiac Disease Shows Higher Complication Risk
European Medical Journal10 Oct · 23:44← All topics · now
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Right now
People with type 2 diabetes and coeliac disease may face higher complication risks.
15 reports · the last 24 hours
Summary · from headlines5 points
- FDA authorized the first continuous ketone monitor for diabetes.
- Retatrutide and survodutide made inroads into weight loss for diabetic patients.
- A new, stronger GLP-1 is currently in clinical trials.
- An experimental add-on drug boosted weight loss in diabetes patients on Dulaglutide.
- FDA approved weight loss drugs for diabetes.
Latest developments6 to read first
fda approved weight loss drugs for diabetes
BusinessWorld Online10 Oct · 10:14ozempic diabetes drug for weight loss
BusinessWorld Online10 Oct · 10:04Molecular regulator CA8 may offer new therapeutic target for type 2 diabetes
News-Medical10 Oct · 10:04new diabetes drug for weight loss
BusinessWorld Online10 Oct · 09:54Will the FDA Approve Retatrutide?
NEXT.io10 Oct · 09:44Timeline 15 reports
10 Oct 202615 reports
23:001 report
22:00nothing heard
21:00nothing heard
20:00nothing heard
19:00nothing heard
18:00nothing heard
17:00nothing heard
16:00nothing heard
15:00nothing heard
14:00nothing heard
13:00nothing heard
12:00nothing heard
11:00nothing heard
10:003 reports
09:003 reports
08:00nothing heard
07:001 report
06:00nothing heard
05:005 reports
04:00nothing heard
03:002 reports
← All topics · nowOne topic